Rejuvesol NDC 23731-7000

NDC codes

FDA NDC Directory

Product NDC (as listed)23731-7000Labeler and product segments. Claims need a package NDC.

Product NDC at billing width23731-7000Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
23731-7000-5	23731700005	12 VIAL, SINGLE-USE in 1 CASE (23731-7000-5) / 50 mL in 1 VIAL, SINGLE-USEMarketed from Feb 26, 1997

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Rejuvesol
Generic name (nonproprietary): sodium pyruvate, inosine, adenine, sodium phosphate, dibasic, and sodium phosphate, monobasic, monohydrate
Active ingredients: Sodium pyruvate — .55 g/50mLInosine — 1.34 g/50mLAdenine — .034 g/50mLSodium phosphate, Dibasic — .73 g/50mLSodium phosphate, Monobasic, Monohydrate — .311 g/50mL
Dosage form: Solution
Route: Extracorporeal
Labeler: Citra Labs, LLC
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication BN 950522
Marketing start: Feb 26, 1997
Listing expires: Dec 31, 2026
Identifiers: Product ID 23731-7000_f07bc3c3-29f0-4f71-9696-47a1c2ec5bf2SPL ID f07bc3c3-29f0-4f71-9696-47a1c2ec5bf2SPL set ID bc06c40f-81a0-45e5-80b6-61f67d445068UNII POD38AIF08, 5A614L51CT, JAC85A2161, GR686LBA74, 593YOG76RN

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

NDC on a medical claim

N423731700005 followed by a unit qualifier and the quantity

Package 23731-7000-05. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Feb 14, 2023.

Indications (excerpt from the label)

INDICATION AND USAGE Rejuvesol ® Solution is intended only to be used as an in vitro processing solution for the rejuvenation of a unit of RBC. RBC may be rejuvenated after storage in CPD (non-leukocyte reduced), CPDA-1, (non-leukocyte reduced), CPD/ADSOL ® (CPD/AS-1 leukocyte reduced), or CP2D/Nutricel ® (CP2D/AS-3, leukocyte reduced). The final concentration of ATP and 2,3-DPG achieved after rejuvenation will vary depending on the number of days of liquid storage at 1-6 °C prior to rejuvenation. NOTE: For simplicity, RBC stored in CPD (non-leukocyte reduced), CPDA-1 (non-leukocyte reduced), CPD/ADSOL ® (CPD/AS-1 leukocyte reduced), CP2D/Nutricel ® (CP2D/AS-3, leukocyte reduced) are referre…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)